Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | HBB | P68871 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | ADK | P55263 | 12/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12616703 | 1.00 | LMNA (0.58) | LMNATSHRMAPTPMP22HBB | |
| SCHEMBL14388655 | 1.00 | LMNA (0.58) | LMNATSHRMAPTPMP22HBB | |
| SCHEMBL12302003 | 1.00 | LMNA (0.58) | LMNATSHRMAPTPMP22HBB | |
| Doxifluridine SCHEMBL27598202 | 0.86 | LMNA (0.58) | LMNATSHRMAPTPMP22HBB | |
| SCHEMBL19657131 | 0.85 | LMNA (0.56) | LMNATSHRMAPTPMP22HBB | |
| SCHEMBL10013535 | 0.85 | LMNA (0.56) | LMNATSHRMAPTPMP22HBB | |
| SCHEMBL331945 | 0.85 | LMNA (0.56) | LMNATSHRMAPTPMP22HBB | |
| SCHEMBL12029778 | 0.85 | LMNA (0.56) | LMNATSHRMAPTPMP22HBB | |
| SCHEMBL15119375 | 0.85 | LMNA (0.56) | LMNATSHRMAPTPMP22HBB | |
| SCHEMBL2467656 | 0.85 | LMNA (0.56) | LMNATSHRMAPTPMP22HBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7365188-B2 | Process for producing N4-Acyl-5′-deoxy-5-fluorocytidine | ROCHE COLORADO CORPORATION (US) | 2008-04-29 | — | — | US | disclosed |